Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Germany

Research and Innovation Action · Finished

CYLCOMED Cyber securitY tooLbox for COnnected MEdical Devices

Coordinator
Charite - Universitaetsmedizin Berlin, Germany
Runs
1 December 2022 to 30 November 2025
Status
Finished
EU funding
€3.5m
Total cost
€3.5m
Partners
11 organisations in 7 countries
Type
Research and Innovation Action
Grant agreement
101095542

What the project is doing

In the project's own words, from its summary on CORDIS.

Accelerated digitalisation in health sector brings opportunities for cost-effective and efficient delivery of personalised care, through medical devices (including software) connected to IT networks and increasingly combined with novel technologies (AI, cloud computing, blockchain or 5G networks) and simultaneously Europe is witnessing an increase in the complexity and sophistication of attacks threatening such critical infrastructure.

CYLCOMED addresses the overall ambitious goal of strengthening the cybersecurity of connected, in vitro diagnostic and software as medical devices (CMDs, IVDs, SaMD), maintaining their performance and safety for patients and preserving or enhancing the confidentiality, integrity and availability of private data they exchange or allow to be remotely accessed and focusing on humans operating the technology as the weakest link in the chain for security and privacy, with training and awareness measures tailored to healthcare staff needs.

It does so by enabling adoption by all ecosystem stakeholders of technologically sovereign and trustworthy cybersecurity methodologies and toolboxes for connected medical devices and the environments in which they are managed and operate (platforms), complemented with fit-for-purpose guidance covering identifed risks and gaps. It will further deliver: (i) risk assessment framework with risk benefit analyses schemes and (ii) toolbox addressing cybersecurity risks and gaps in connected medical devices;(iii) assessment and extension of baseline standards, best practices and guidelines covering challenges for CMDs including SW, making them fit for purpose when used in conjunction with novel technologies; (iv) demonstrations and case studies in relevant on premise hospital scenarios (COVID-19 patients monitoring) and remote telemonitoring scenarios improving the life of paediatric patients.

CYLCOMED has 9 partners from 7 EU Member States and 1 associate partner from Switzerland and a duration of 36 months.

Topics

Who is involved

OrganisationCityCountryRole
Charite - Universitaetsmedizin BerlinBerlinGermanyCoordinator
Katholieke Universiteit LeuvenLeuvenBelgiumParticipant
Martel GmbHDubendorfSwitzerlandAssociatedpartner
Atos It Solutions and Services Iberia SLMadridSpainThird party
Atos Spain SAMadridSpainParticipant
Fundacion Para La Investigacion Biomedica Hospital Infantil Universitario Nino JesusMadridSpainParticipant
R G B Medical Devices SAMadridSpainParticipant
Mediaclinics Italia SRLTrento TnItalyParticipant
Ospedale Pediatrico Bambino GesuRomaItalyParticipant
Inov Instituto De Engenharia De Sistemas E Computadores InovacaoLisboaPortugalParticipant
Xlab Razvoj Programske Opreme in Svetovanje DooLjubljanaSloveniaParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI